Prof Peter Allen, from our Department of Vision & Hearing Sciences and Vision and Eye Research Unit, is part of a team awarded just over £1.2 million from the National Institute for Health Research Efficacy and Mechanism Evaluation scheme, to investigate myopia in children.
Myopia is a major and increasing public health problem, as it is associated with ocular co-morbidities, blindness, and substantial NHS and societal costs. Most often myopia appears during childhood and progresses over the first two decades of life. Various interventions designed to reduce the progression of myopia are being investigated around the world.
The 2-year multi-centre trial aims to evaluate the efficacy, tolerability, and mechanism of low dose atropine eye drops to reduce progression of myopia in children. The centres are located in Belfast, Glasgow, Birmingham and Cambridge, at our Anglia Ruskin University Eye Clinic. The trial will start recruiting children with myopia later in 2017.